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ABSTRACT 
Oligonucleotide probes derived from (I) the T3 RNA polymerase promoter sequence (T3) and (2) prostate-specific antigen 
messenger RNA (PSA) were prepared and labeled with a red-emitting fluorescent dye (Cy5). The complimentary 
oligonucleotides (anti T3 and anti PSA) were prepared and labeled with biotin. Initially, a feasibility study was performed in 
which the hybridization rate of the T3/anti T3 oligonucleotide pair was examined. Specifically, biotinylated anti T3 was 
immobilized to a neutravidin-coated waveguide and solutions containing increasing concentrations of Cy5-labeled T3 were 
injected into the biosensor. Fluorescence emission was detected with an evanescent wave imaging fluorometer. The 
hybridization reaction proceeded rapidly with a significant amount of binding occurring during the first 5 minutes. A 
Michaelis-Menton kinetics model was used to analyze hybridization rate data and gave values of 78 nanomolar for the 
apparent affinity of the hybridization reaction and 1.4 picomolar for the analytical sensitivity of the hybridization assay. In 
subsequent studies the hybridization rate of the PSA/anti PSA oligonucleotide pair was examined. Biotinylated anti PSA was 
immobilized to the waveguide and solutions containing increasing concentrations of Cy5-labeled PSA were injected into the 
biosensor. The hybridization rate observed for formation of the PSA/anti PSA pair was comparable to the high rates 
observed for the T3/anti T3 pair. Lastly, the selectivity of the biosensor was examined using an oligonucleotide probe 
derived from human glandular kallikrein (hGK), which exhibits a high degree of homology to PSA. The two oligonucleotide 
probes (PSA and hGK) only differed in 7 out of 20 positions. Interestingly, the hybridization rate observed for Cy5-labeled 
hGK was very low-not statistically different from the non-specific binding rate of the hybridization assay. 
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1. INTRODUCTION 
There have been several reports to date of the use of optical biosensors for performing molecular diagnostics (MDx) assays. 
Although a majority of these were either fluorescent fiber optic sensors l -3 or label-free surface plasmon resonance (SPR) 
sensors,4-8 several other label-free evanescent wave formats have been described including interferometry,9 diffractometrylO 
and evanescent-illuminated light scatter. I I, 12 Two of these articles are particularly relevant because they report the use of 
evanescent wave biosensors in clinical applications. First, Nilsson et al.S used surface plasmon resonance to detect the 
presence of the human tumor suppressor p53 gene in breast tumor biopsy material. Moreover, these authors were able to 
detect point mutations in clinical DNA specimens because polymerase chain reaction (PCR) products containing mismatched 
bases gave reduced levels of hybridization relative to the wild type. This result illustrates an important feature of biosensor 
technology in MDx assays-namely, the ability to monitor the hybridization reaction in real time provides a powerful tool for 
identifying mismatched bases. Second, Pilevar et al.3 were able to detect 25 pM levels of Helicobater pylori RNA using a 
fluorescent fiber optic sensor. This result is very encouraging because it shows that fluorescent evanescent wave sensors are 
capable of performing high sensitivity MDx assays. The real question is whether such sensors can be used in high 
throughput genetic screening applications where hundreds, if not thousands, of hybridization assays would need to be 
performed in parallel on the same biosensor. 
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2. BIOSENSOR FORMAT FOR HYBRIDIZA nON ASSAYS 
Evanescent wave biosensors can be designed to function either with or without fluorescent labels. Surface plasmon 
resonance and other label-free optical sensors respond to mass changes in the evanescent wave. In our opinion, mass sensors 
have at least two limitations over fluorescent sensors. First, a mass sensor will respond to any molecule bound within the 
evanescent wave-whether it is bound specifically or non-specifically. For this reason, nonspecific binding (NSB) can be a 
significant problem with these sensors and both Biacore AB and Affinity Sensors have devoted significant effort to 
developing immobilization chemistries with low NSB. In contrast, detection in a fluorescent biosensor is accomplished by a 
fluorescently-labeled "tracer" molecule that binds specifically (through an affinity interaction) to the ligand-capture molecule 
complex; alternatively, a fluorescently-labeled analyte molecule can bind directly to the immobilized capture molecule. This 
latter case is more appropriate for nucleic acid hybridization assays where the fluorescent label can be directly incorporated 
into the analyte molecule using PCR. In either case, NSB is only an issue with the fluorescent-labeled molecule, rather than 
with any molecule that happens to be in the evanescent wave. 
The second limitation of mass sensors is that they require a significantly larger sensing area than a fluorescent sensor does to 
measure a given concentration (because mass detection is less sensitive than fluorescent detection). For this reason, it is 
difficult to construct medium- and high-density array biosensors using SPR technology. For that matter, fiber optic 
fluorescence sensors are not particularly well suited for medium- and high-density applications either because a separate 
sensor fiber would be required for each nucleotide sequence being examined. For these reasons, we believe that planar 
waveguide sensors are the best choice for rapid, high throughput genetic testing. Furthermore, a t1uorescent assay format 
should afford greater sensitivity than can be achieved with label-free biosensors such as BIACORE® or IAsys®. A planar 
waveguide fluorescent sensor for detection of nucleic acid hybridization is shown diagrammatically in Figure 1. 
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Figure 1. Oligonucleotide hybridization assay using a planar waveguide biosensor. Light is totally reflected within the 
waveguide, setting up an evanescent wave that decays a few hundred nanometers into the sample. Fluorescently-Iabeled 
analyte molecules hybridize to capture oligonucleotides that are attached to the waveguide. Once in the evanescent field, the 
label fluoresces. 
3. EXPERIMENTAL PROCEDURES 
3.1. Waveguides 
An injection-molded planar waveguide sensor was used in all DNA hybridization studies described herein. These sensors are 
based on a design patented by two of the authors (Herron and Christensen).13-15 Sensors were molded from polystyrene by 
Opkor, Inc. in Rochester, NY and are both disposable and relatively inexpensive, making them ideal for assay development 
purposes. A schematic illustration of an injection-molded planar waveguide sensor is shown in Figure 2. In addition to the 
waveguide, the sensor contains two lens-an in-coupling lens used for coupling light into a waveguide and an exit lens used 
to dump light out of the waveguide. Capture oligonucleotides are immobilized to the top of the planar waveguide and 
fluorescence emission is collected from the bottom of the waveguide (orthonormal to the plane of the waveguide) using a 






Figure 2. Injection-molded planar waveguide sensor. The waveguide and in-coupling lens are incorporated into the same 
disposable unit for greater alignment tolerance. This particular version also contains an exit lens for dumping light out of the 
sensor in a graceful manner. Exciting light (typically generated by a 635 nm diode laser) is collimated into a sheet beam (ca. 
20 mm x 2 mm) and steered into the coupling lens. After being coupled, the light propagates down the waveguide setting up 
the evanescent field. Capture oligonucleotides are immobilized to the top of the planar portion and hybridization assays are 
performed as described in Figure I. 
3.2. Flowcells 
The injection-molded waveguide sensors were used in conjunction with a flowcell developed by Herron, Christensen and 
Reichert. 16- 19 In brief, flowcells were constructed from two separate pieces-a top and a bottom plate-that were fabricated 
from aluminum. Three different types of top plates were milled that had either one, two or three parallel flow chambers, each 
with small inlet and outlet ports. The interior of the bottom plate was milled to support the waveguide and provide a clear 
view of its bottom. The entire flowcell was anodized flat black. The top plate was sealed against the waveguide using a 
composite gasket with a low-refractive index Teflon™ layer next to the waveguide and a silicon rubber layer next to the top 
plate. Mechanical pressure to seal the system was produced by tightening four knurled bolts located at the four comers of the 
flowcell. 
A computer-controlled 3-barrel syringe pump (Cavro Scientific Instruments Inc.) was used to inject specimens into the flow 
chambers. The sample volume of each chamber was 100 J.lL. The syringe pump was controlled by an instrument control and 
data acquisition program that was written in the LabView macro language. This software runs on either MacOS or Windows 
platfonns. 
The availability of different top plates (1-, 2- or 3-chamber) affords some flexibility in experimental design. For example, the 
PCR product from a single patient could be screened for a large number of mutations using a single chamber flowceIl, or 
PCR products obtained from three different patients could be screened for a smaller number of mutations using a 3-chamber 
flowcell. Alternatively, the extra chambers could be used for calibration purposes. For instance, the patient's sample could 
be injected into one chamber, while positive and negative controls are injected into the other two chambers. 
3.3. Optical Configuration 
All fluorescence measurements were taken with a Mark J.5 evanescent wave imaging fluorometer that was constructed at the 
University of Utah. Waveguides were mounted in the flowcell to form the sensor assembly as described above. The sensor 
assembly was then locked into a mounting plate on the Mark 1.5 fluorometer that provides tight registration of the waveguide 
to the exciting light. A diode laser that emits 12 mW of red light at 635 nm was used as the light source. The output of this 
laser was formed into a sheet beam using a series of collimating lenses and then reflected with a mirror into the coupling lens 
in the case of the waveguide. 
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Once trapped inside the waveguide, the light bounced from side to side of the waveguide setting up an evanescent field at 
each reflection point. This field decayed about 100nm into the solution in the tlowcell and excited Cy5-labeled nuc1eotides 
that were hybridized to the immobilized capture nucleotides. Fluorescence emission emanated in all directions, but the 
portion that travels through the waveguide (and through a window in the bottom of the tlowcell) was collected and imaged by 
a CCD camera (Santa Barbara Instrument Group). This camera was equipped with a 55 mm f/2.8 macro Jens (Nikon) to 
focus the light and a 670 nm bandpass interference filter (Orion) to reject scattered light. The CCD image was collected and 
processed by the aforementioned instrument control and data acquisition program that was written in the LabView macro 
language. This software "binned" the image into different spatially-resolved sensor zones and also used a non-linear least 
squares fitting routine to compute the average hybridization rate of a data set over a 5 min. assay period. 
4. RESULTS AND DISCUSSION 
Our evanescent planar waveguide technology is generic in the sense that it can be used to monitor almost any sort of affinity 
interaction between biomolecules. Nucleic acid hybridization is an affinity interaction, similar in some respects to antigen-
antibody interactions; so it seemed only natural to investigate whether our biosensor system could be used to monitor the 
hybridization of two complementary oligonucleotides in real time. The T3 RNA polymerase promoter site was chosen as a 
model system for this feasibility study. The T3 site is a region spanning 20 bases with the following sequence: 5' 
AA TTAACCCTCACTAAAGGG 3'. Oligonucleotide primers for both this sequence (T3) and its complementary sequence 
(anti T3) are commercially available. They have also been fluorescently labeled and used in nucleic acid sequencing.20 
We decided to employ the avidinlbiotin system for immobilizing the T3 oligonucleotide to the waveguide. This choice was 
based upon a previous observation that avidin adsorbed strongly to injection-molded waveguides.21 The T3 20-mer was 
biotinylated at the 5' end via a six-carbon spacer. It was then immobilized to waveguides (either injection-molded or 
integrated optical) that had been coated previously with either avidin or neutravidin. The anti T3 20-mer was labeled at the 5' 
end with Cy5, a red-emitting fluorescent dye. It should be mentioned that this Cy5-labeled analyte is very similar to analytes 
that are used in clincial MDx assays. Such clinical analytes are prepared by polymerase chain reaction and CyS-labeled 
primers can be used to initiate DNA synthesis. Thus, the PCR product can be made to contain Cy5 dye at its 5' end. 
The kinetic response of our injection-molded biosensor for the T3/anti T3 hybridization reaction is shown on the next page in 
Figure 3, along with three controls. The same analyte solution (10 nM Cy5-labeled anti T3) was injected into the flowcell in 
all four cases, but a different capture molecule (or complex) was examined in each case. Nonspecific binding ofCy5-anti T3 
to either avidin or neutravidin is depicted in open circles and open squares, respectively. Interestingly, a significant level of 
NSB was observed with avidin, but not with neutravidin; presumably because avidin has a high pI value and is positively-
charged at pH 7.4, which can lead to electrostatic interactions with the negatively-charged tracer oligo. Because of this 
observation, neutravidin was used instead of avidin in all subsequent studies. The third control examined whether there was 
any nonspecific binding between two oligos with the same nucleotide sequence. In this case, biotinylated anti T3 was 
immobilized to a neutravidin-coated waveguide (closed diamonds). As can be seen from the figure, binding between like 
oligos was negligible. Finally, hybridization between complementary oligos was examined by immobilizing biotinylated T3 
to a neutravidin-coated waveguide (closed circles). In this case, very strong binding was observed, reaching 107 sensor units 
in less than two minutes. 
Next, T3/anti T3 hybrization assays were performed at room temperature for a number of different concentrations of Cy5-
labeled anti T3, ranging from 10 pM to 100 nM. Hybridization rate was plotted versus tracer oligo concentration in Figure 4 
on the next page. A double log plot was used because of the wide dynamic range (4 orders of magnitude) of the assay (the 
same data is plotted on linear axes in the inset). Once again, the data was found to fit a Michaelis-Menton model with a 
Michaelis constant of about 78 nM (curve-fitting parameters are also shown in the figure). An analytical sensitivity value of 
1.4 pM was computed for these data. 
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Figure 3. Hybridization ofCy5-labeled anti T3 to several different capture molecules (or complexes). Open circles: 
nonspecific binding to immobilized avidin. Open squares: nonspecific binding to neutravidin. Closed diamonds: nonspecific 
binding to immobilized biotin-anti T3/neutravidin complex. Closed circles: hybridization to immobilized biotin-
13/neutravidin complex. 
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Figure 4. Standard curve for the hybridization ofCy5-anti 13 to immobilized T3. The sensitivity of our T3/anti T3 
hybridization assay using injection-molded waveguides was investigated by spiking human Cy5-labeled anti-T3 into PBS. 
Hybridization rate was plotted versus Cy5-anti T3 concentration to construct the standard curve. An analytical sensitivity 
(defined as 2a/slope, where cr is the standard deviation of the zero rate) value of 1.4 pM was determined for the assay. 
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Having established that our planar waveguide sensors can be used to monitor nucleic acid hybridization reactions, we decided 
to evaluate our biosensor system in a molecular diagnostics assay for the messenger RNA that encodes for prostate specific 
antigen (PSA). It turns out that PSA exhibits a high degree of homology to another human protein, glandular kallikrein 
(hGK2), that is also secreted by the prostate gland.22-24 For this reason, it is important that the immobilized hybridization 
probe bind only to cDNA derived from the PSA message and not to that derived from the hGK2 message. We identified a 
region in exon 4 of the PSA gene where the sequence differs from hGK2 in 7 out of 20 positions. A hybridization probe (5' -
GGGGC AAAAGCACCTGCTCG-3', referred to as "anti PSA") that recognizes this sequence was synthesized and 
biotinylated at the 5' end. Two additional oligonucleotides were synthesized, labeled with Cy5, and then used as model 
analytes. One of these (5' -CGAGCAGGTGCTTT TGCCCC-3', referred to as "PSA") was derived from the cDNA sequence 
ofPSA, while the other (5'-CCA·CAA GTGTCTTTACCAC -3', referred to as "hGK2") was derived from the cDNA 
sequence ofhGK2. The biotinylated probe was immobilized to a neutravidin-coated, injection-molded waveguide and a 1 nM 
solution of either Cy5-labeled PSA or Cy5-labeled hGK2 was injected into the flowcell. Hybridization kinetics curves are 
shown in Figure 5 for both of these reactions. A very high hybridization rate was observed for the homodupJex, while the rate 
observed for the heteroduplex was not statistically above background. 
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Figure 5. Hybridization kinetics of two Cy5-labeled oligonucleotides (PSA & hGK2) to an immobilized oligonucleotide 
(anti PSA). An analyte concentration of 1 nM was used for both Cy5-labeled oligonucleotides. PSA and anti PSA are 
perfectly complementary and exhibited a high hybridization rate (1.5xl06 sensor units per minute). The hGK2 and anti PSA 
oligonucleotides have mismatched bases in 7 out of 20 positions and exhibited a much lower hybridization rate (2800 
SUlmin.). This rate was not significantly different from the nonspecific binding rate of this assay (513±1416 SU/min). 
5. CONCLUSIONS 
We conclude from these studies that our injection-molded planar waveguide sensors are well suited for performing nucleic 
acid hybridization assays. The 1.4 pM sensitivity observed for the T3/anti T3 system compares very favorably to the 25 pM 
sensitivity obtained by Pilevar et al.3 for Helicobater pylori RNA using fluorescence fiber optic sensor technology. Our 
ability to perform rapid (:55 min.) assays offers the additional advantage of being able to monitor hybridization reactions in 
real time. Another important feature is the ability to distinguish between two closely-related analytes (PSA and hGK) that 
would both be present in the same clinical specimen. Taken together, these capabilities make our biosensor system well 
positioned for performing MDx assays in point-of-care and critical care settings. 
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